Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02524418 · ClinicalTrials.gov registry record · NA
Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS
A NA study, sponsored by University of Florida.
- Completed
- Registry status
- NA
- Development phase
- 88
- Enrollment target
NCT02524418 is a NA study that has completed, run by University of Florida. The registered enrollment target is 88 participants.
The verdict
NCT02524418, a NA study, has completed, sponsored by University of Florida.
- COMPLETED
- Registry status
- NA
- Development phase
- 88 participants
- Enrollment target
Study Summary
This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and management of pancreatic-biliary disorders.
Interventions
- PROCEDURE Cholangiopancreatoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 88 participants |
| Start Date | 2015-08 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02524418
The ClinicalTrials.gov registry entry for NCT02524418 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 88 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cholangiopancreatoscopy is the first listed.
NCT02524418 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02524418 about?
NCT02524418 is a clinical study titled "Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS". This is a prospective evaluation of the clinical utility of the new cholangioscopy platform SpyGlass DS. The aims of this study are to prospectively document the clinical utility and technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and management of pancreatic-bil...
What is the current status of trial NCT02524418?
This trial is currently completed. It is a NA study. The enrollment target is 88 participants. The study started on 2015-08. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02524418?
The interventions under investigation include: Cholangiopancreatoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02524418?
This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.